SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending as a report surfaced regarding security flaws in a battlefield communication system, triggering a sharp sell-off despite the company's rebuttal and claims that the issues were resolved. The community is debating the severity and validity of the report, with some viewing it as a buying opportunity while others express concerns about the company's valuation. Discussions also involve the potential impact on government contracts and the trustworthiness of news sources.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amid discussions around Novo Nordisk's potential entry into the telehealth space with an obesity pill, which could impact HIMS' market share, while others are pointing out that weightloss is only a small part of the business. The community is debating whether this news presents a buying opportunity or signals a concerning shift in the competitive landscape, especially since some are looking at the COO exit as a negative catalyst. Some traders are noting technical levels and expressing frustration with the stock's volatile price action and seeming sensitivity to news.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as investors discuss its potential U.S. expansion and speculate on a possible Nasdaq relisting, with community members pointing to strong fundamentals driving the stock. The company's growth in China, coupled with Starbucks' struggles, is fueling optimism, while others remain cautious due to past accounting issues and the stock's OTC status.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending as retail investors and traders discuss its impressive recent gains and potential for future growth within the quantum computing sector. Community members are weighing the possibility of a short squeeze against concerns of overvaluation and a potential offering, while some highlight a recent purchase order announcement. The stock's momentum is drawing attention, with debates swirling around its long-term prospects compared to others in the quantum computing space.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation ($ACHR) is trending amid high trading volume and anticipation surrounding potential catalysts, including upcoming airshows and FAA certification progress. The community is actively discussing the possibility of a short squeeze, as well as potential partnerships, with some drawing attention to Tesla's presence in a recent promotional video. Discussions also involve comparisons to sector peer Joby Aviation, with some traders anticipating $ACHR closing the market cap gap.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending as investors debate its AI spending and monetization strategies, highlighted by a recent report on AI chatbots exploring ad revenue. Community chatter reflects concerns about its recent price action, with some viewing it as a buying opportunity while others express bearish sentiment. Broader discussions include Meta's competition in the AI and AR spaces, particularly around its smart glasses.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth (USAR) is trending due to speculation surrounding potential US government investment, fueled by the CEO's confirmation of White House discussions; the community is debating the significance of these talks and comparing USAR to other rare earth companies like MP Materials and LAC. Some investors are concerned about potential dilution from share unlocks and insider selling, while others remain optimistic about USAR's role in securing a domestic rare earth supply chain amid increasing geopolitical tensions.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is trending amid speculation of a potential buyout, with community members pointing to increased volume and options activity as possible indicators. Chatter suggests that a big tech company could be interested in acquiring the AI firm to bolster its own AI capabilities. Despite recent financial results and leadership changes, the stock is seeing increased interest.

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Clene Inc

CLNN is trending as community members discuss the potential for accelerated approval of its ALS treatment following positive commentary from the FDA. Conversations revolve around the company's cash flow, potential offerings, and the possibility of a data leak driving the recent price movement. Some investors express excitement and relief, while others remain cautious due to past experiences and the need for further positive developments.

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.

Alto Neuroscience Inc.

Alto Neuroscience is trending amid community discussion around a potential short squeeze and recent gains. Some traders cite the company's fundamentals, upcoming data readouts, and potential for a large upside. Others remain cautious, pointing to past trial failures and ongoing discussions about a possible offering.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hinge Health received widespread bullish initiation coverage on Monday from a dozen brokerages, with analysts highlighting its leadership in digital musculoskeletal (MSK) care, strong margins, and scalable AI platform.The stock ended 3.9% higher at $36.21 on Monday.Piper SandlerPiper Sandler started the stock at ‘Overweight’ with a $41 target, noting Hinge’s proprietary technology and sophisticated distribution strategy as drivers for sustained double-digit revenue growth.&nbsp;The firm pointed to a 2.4x or greater return on investment across commercial and Medicare populations, with durable 80%-plus gross margins and operating leverage as the company scales beyond its 2,250 clients and 20 million contracted lives as of Dec. 31, 2024.CanaccordCanaccord also began with a ‘Buy’ rating and a $52 target, describing Hinge as a “true innovator” disrupting traditional physical therapy through an AI-powered platform.&nbsp;The firm cited automation of 95% of care and emphasized the defensibility of Hinge’s position in the digital MSK market.BofABofA launched coverage with a ‘Buy’ rating and $42 target, calling Hinge the “digital physical therapy leader” with competitive advantages in its customer base, motion-tracking tech, and partnerships with five of the largest U.S. health plans.NeedhamNeedham began coverage with a ‘Buy’ rating and $47 target, calling Hinge the market leader in virtual MSK care and pointing to its advantages over digital competitors and legacy in-person providers.&nbsp;The firm noted that while 40% of Americans suffer from MSK issues, only 9% get treatment, creating a large untapped opportunity.William BlairWilliam Blair rated the stock ‘Outperform’ and described it as a core healthcare technology holding.&nbsp;The firm pointed to Hinge’s personalized digital app and supportive valuation at 5x 2026 revenue and 6.4x adjusted gross profit.Evercore ISIEvercore ISI also rated the stock ‘Outperform’ with a $50 target, citing broad employer and plan adoption and a multi-condition offering that supports continued 20% annual growth.TruistTruist gave it a ‘Buy’ rating and&nbsp;a $48 target, highlighting “enduring structural advantages,” strong outcomes data, and a flywheel driven by AI, partner networks, and attractive economics.StifelStifel started Hinge with a ‘Buy’ and $48 target, describing a platform that combines mobile app-based care with messaging and licensed PTs.&nbsp;The firm noted that Hinge became profitable and free cash flow positive in 2024, with room for further margin gains.RBC CapitalRBC Capital gave an ‘Outperform’ rating and&nbsp;a $45 target, saying the firm is well-positioned to scale digital MSK care across commercial, Medicare Advantage, and global markets, supported by strong validation and 20M covered lives.KeyBancKeyBanc began with an ‘Overweight’ and $45 target, describing Hinge as the clear leader in a large and underserved healthcare segment.&nbsp;The firm believes the recent 17% decline in share price post-IPO presents an attractive entry point.BarclaysBarclays also rated the stock ‘Overweight’ with a $43 target, saying Hinge can “bend the cost curve” in MSK with its tech and partnerships, and sees 15–20% billings growth translating into 20% revenue expansion.On Stocktwits, retail sentiment was ‘bearish’ amid ‘low’ message volume.The stock has declined 3.6% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Hinge Health logo is seen displayed on a smartphone and in the background. (Photo Illustration by Avishek Das/SOPA Images/LightRocket via Getty Images)

Wall Street Turns Bullish On Hinge Health As Analysts Laud Profitable Growth, AI Disruption In MSK Care

Analysts noted Hinge Health’s strong return on investment, rapid automation of care delivery, and profitability milestones as key drivers of their bullish stance.

Equity

Wall Street analysts start with bullish ratings on Hinge Health on growth potentia

Investing.com -- Shares of  Hinge Health  Inc (NYSE:HNGE) drew bullish coverage from several brokerages as analysts cited the company’s position as a leading provider of virtual physical therapy and highlighted its expanding market opportunity, improving margins, and adoption of artificial intelligence.

Virtual&nbsp;healthcare provider Omada Health&nbsp;(OMDA)&nbsp;priced its initial public offering (IPO) at $19 per share,&nbsp;at the midpoint of the previously estimated price range of $18 and $20 per share&nbsp;as per an amendment to the S-1 filing made in late May.The offering is expected to close on&nbsp;June 9.The San Francisco-based company&nbsp;would sell&nbsp;7.9 million shares of its common stock. Based on the IPO pricing, the company is set to raise gross proceeds of over $150 million.Additionally, Omada Health has given underwriters a 30-day option to buy up to 1.2 million&nbsp;additional&nbsp;shares of common stock at the IPO price, excluding underwriting discounts and commissions.At the IPO price, Omada is valued at around $1.1 billion, with the potential for a higher valuation on a fully diluted basis. It had raised $192 million in a Series E funding round led by Fidelity Management &amp; Research in February 2022.The shares are set to begin trading on the Nasdaq Global Select Market under the ticker symbol “OMDA” on June 6, 2025.Morgan Stanley, Goldman Sachs &amp; Co, and J.P. Morgan are serving as lead book-running managers for the offering. Barclays and Evercore ISI are acting as joint book-running managers, while Canaccord Genuity and Needham &amp; Company are serving as co-managers.Last month, digital physical therapy company Hinge Health&nbsp;debuted on the NYSE at $39.25 per share, 23% higher than its&nbsp;IPO price of $32. The shares have risen 20% since then.Omada provides virtual care programs designed to help patients manage chronic conditions such as prediabetes, diabetes, and hypertension. According to the prospectus, its revenue increased by 57% year-on-year to $55 million in the quarter ended March 31, 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, an IPO (Initial public offering) words are seen on a smartphone screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Omada Health Prices $150M IPO In-Line With Estimated Range

Omada Health (OMDA) priced its IPO at $19 per share, midpoint of the previously estimated price range of $18.00 and $20.00 per share

Omada Health (OMDA) priced its IPO at $19 per share, midpoint of the previously estimated price range of $18 and $20 per share

Shares of California-based Hinge Health, Inc. (HNGE) jumped 19% above its initial public offering price on Thursday in its debut on the New York Stock Exchange (NYSE).Shares of the company, which leverages software to automate care for joint and muscle health, opened at $39.2 before paring back some gains.<a href="https://stocktwits.com/symbol/HNGE">Hinge</a> said on Wednesday that the company and some of its selling stockholders sold 13.67 million shares of its common stock at an initial public offering price of $32 to raise about $437.3 million. &nbsp;Hinge Health was founded in 2014 by Daniel Perez and Gabriel Mecklenburg and is backed by venture capital firm Insight Partners. It announced its intent to go public in March.The firm made revenue of $123.8 million in the first quarter and net income of $17.1 million.A Stocktwits user opined that the stock might be “worth watching.”<stembedurl>https://stocktwits.com/ReWorkinvest/message/615490699</stembedurl>Connected TV advertising platform MNTN (MNTN), of which actor Ryan Reynolds is Chief Creative Director, also debuted on the NYSE on Thursday. Shares of the Austin-based company opened at $21, up 31% from its IPO price of $16.Blackrock-backed <a href="https://stocktwits.com/symbol/MNTN">MNTN</a> had reportedly put its IPO ambitions on hold in early April after President Donald Trump’s tariffs stirred up market turmoil.However, the recently announced 90-truce between China and the U.S, which resulted in significantly reduced tariffs on imports, has rekindled market confidence.Last week, Israeli multi-asset investment and social trading company eToro (<a href="https://stocktwits.com/symbol/ETOR">ETOR</a>) debuted on Nasdaq and opened at $69.69, up from its IPO price of $52.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/lightspeed-commerce-q4-2025-earnings/ch09kuhRbpy">Lightspeed Commerce Stock Slides As Impairment Charge Hits Earnings: But Retail’s Optimistic</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Hinge Health, MNTN Shares Soar In NYSE Debut

Hinge Health was founded in 2014 by Daniel Perez and Gabriel Mecklenburg and is backed by venture capital firm Insight Partners.

Hinge Health IPO surges 23% on debut

Investing.com -- Today’s IPO for healthcare service  Hinge Health  Inc (NYSE:HNGE) opened for trading at $39.25 per share after pricing 13,666,000 shares of common stock at $32 per share, the top end of the expected $28-$32 range.

Hinge Health, Inc. operates as a digital healthcare company that develops software for joint and muscle health care. It leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for its clients. The company has designed its platform to address a broad spectrum of MSK care, ranging from acute injury, to chronic pain, to post-surgical rehabilitation, and the platform can help to ease members’ pain, improve their function, and reduce their need for surgeries, all while driving health equity by allowing members to engage in their exercise therapy sessions from anywhere. Hinge Health was founded by Daniel Perez and Gabriel Mecklenburg in 2014 and is headquartered in San Francisco, CA.

Hinge Health Inc. - Ordinary Shares - Class A

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

HNGE
Hinge Health, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest HNGE News

HNGE Hinge Health, Inc.